NCT01910194View on ClinicalTrials.gov

Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Diabetes Mellitus
Interventions
DRUG

Luyxumia versus Lantus

Trial Locations (2)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

44791

St. Josef-Hospital, University Hospital, Ruhr, Bochum

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT01910194 - Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying | Biotech Hunter | Biotech Hunter